Skip to main content

Table 1 Distribution of participants to the GIBIEX study according to main individual characteristics at enrollment

From: Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]

Characteristics

N

IDN 5933

Placebo

p-value*

 

47

27 [57.5%]

20 [42.5%]

Age [Mean ± SD]

47

79.2 ± 10.7

81.2 ± 10.3

NS

Age Tertiles [%]

47

  

NS

  < 77 years

17

11 [40.7%]

6 [30.0%]

 

 78–85

15

8 [29.6%]

7 [35.0%]

 

  ≥ 86

15

8 [29.6%]

7 [35.0%]

 

Sex [% Male]

18

9 [33.3%]

9 [45.0%]

NS

Marital Status [%]

43

  

NS

 Unmarried

11

8 [32.0%]

3 [16.7%]

 

 Married

9

5 [20.0%]

4 [22.2%]

 

 Divorced

1

1 [4.0%]

 

 Widower

22

11 [44.0%]

11 [61.1%]

 

Education [%]

35

  

NS

 No degree/Elementary

27

13 [76.5%]

14 [77.8%]

 

 Middle School

4

4 [22.2%]

 

 High School/University/Other

4

4 [23.5%]

 

Current Weight Kg [Mean ± SD]

38

68.3 ± 12.8

67.9 ± 18.9

NS

Usual Weight Kg [Mean ± SD]

32

70.4 ± 10.6

67.5 ± 13.5

NS

Height mt. [Mean ± SD]

40

1.64 ± 0.1

1.63 ± 0.1

NS

Smoking habit [%]

47

  

NS

 Never Smoker

20

13 [48.2%]

7 [35.0%]

 

 Current Smoker

7

4 [14.8%]

3 [15.0%]

 

 Ex-smoker

12

7 [25.9%]

5 [25.0%]

 

 Not responding

8

3 [11.1%]

5 [25.0%]

 
  1. *t-test quantitative [for unequal variances] or Chi square qualitative [NS p > 0.05]